Cargando…

Combined use of Amplified Fragment Length Polymorphism and IS6110-RFLP in fingerprinting clinical isolates of Mycobacterium tuberculosis from Kerala, South India

BACKGROUND: DNA fingerprinting by IS6110-RFLP has shown a high incidence of Mycobacterium tuberculosis isolates having no and low copies of the insertion sequence in Kerala, South India. Amplified Fragment Length Polymorphism (AFLP) would scan the entire genome rather than a few repetitive elements,...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Manju Y, Radhakrishnan, Indulakshmi, Joseph, Biljo V, GK, Madhavi Latha, Kumar R, Ajay, Mundayoor, Sathish
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950308/
https://www.ncbi.nlm.nih.gov/pubmed/17662148
http://dx.doi.org/10.1186/1471-2334-7-86
_version_ 1782134541292404736
author Krishnan, Manju Y
Radhakrishnan, Indulakshmi
Joseph, Biljo V
GK, Madhavi Latha
Kumar R, Ajay
Mundayoor, Sathish
author_facet Krishnan, Manju Y
Radhakrishnan, Indulakshmi
Joseph, Biljo V
GK, Madhavi Latha
Kumar R, Ajay
Mundayoor, Sathish
author_sort Krishnan, Manju Y
collection PubMed
description BACKGROUND: DNA fingerprinting by IS6110-RFLP has shown a high incidence of Mycobacterium tuberculosis isolates having no and low copies of the insertion sequence in Kerala, South India. Amplified Fragment Length Polymorphism (AFLP) would scan the entire genome rather than a few repetitive elements, we thought that this technique would help us in differentiating the large reservoir of isolates from an endemic region. Here we evaluate the ability of Amplified Fragment Length Polymorphism (AFLP) to type clinical isolates. METHODS: Fifty clinical isolates of M. tuberculosis were analysed by conventional radioactive AFLP and IS6110- RFLP. M. bovis, M. bovis BCG and two non tuberculous mycobacteria were also analysed to see species specific differences generated by AFLP. Cluster analysis was performed using the AFLP profile that showed the maximum polymorphism within M. tuberculosis and this was compared to the number of copies of IS6110 insertions. RESULTS: For AFLP, out of ten primer pairs tested, the EO/MC pair generated maximum polymorphism among the clinical isolates of M. tuberculosis. The similarity between the isolates ranged between 88 and 99.5%. Majority (nearly 85%) of the 'low copy' IS6110 isolates clustered together, while the rest clustered irrespective of the copy numbers. AFLP could show rare differences between isolates of M. tuberculosis, M. bovis and M. bovis BCG. The AFLP profiles for non-tuberculous mycobacteria were highly different from those of M. tuberculosis. CONCLUSION: Polymorphism generated by AFLP within the M. tuberculosis species is limited and hence AFLP alone seems to have limited use in fingerprinting the isolates in Kerala. The combined use of AFLP and IS6110-RFLP showed relatively better differentiation of 'high copy' IS6110 isolates, but failed to differentiate the 'low copy' isolates. However, the technique may be efficient in inter-species differentiation, and hence potentially useful in identifying and developing species- specific markers.
format Text
id pubmed-1950308
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19503082007-08-21 Combined use of Amplified Fragment Length Polymorphism and IS6110-RFLP in fingerprinting clinical isolates of Mycobacterium tuberculosis from Kerala, South India Krishnan, Manju Y Radhakrishnan, Indulakshmi Joseph, Biljo V GK, Madhavi Latha Kumar R, Ajay Mundayoor, Sathish BMC Infect Dis Research Article BACKGROUND: DNA fingerprinting by IS6110-RFLP has shown a high incidence of Mycobacterium tuberculosis isolates having no and low copies of the insertion sequence in Kerala, South India. Amplified Fragment Length Polymorphism (AFLP) would scan the entire genome rather than a few repetitive elements, we thought that this technique would help us in differentiating the large reservoir of isolates from an endemic region. Here we evaluate the ability of Amplified Fragment Length Polymorphism (AFLP) to type clinical isolates. METHODS: Fifty clinical isolates of M. tuberculosis were analysed by conventional radioactive AFLP and IS6110- RFLP. M. bovis, M. bovis BCG and two non tuberculous mycobacteria were also analysed to see species specific differences generated by AFLP. Cluster analysis was performed using the AFLP profile that showed the maximum polymorphism within M. tuberculosis and this was compared to the number of copies of IS6110 insertions. RESULTS: For AFLP, out of ten primer pairs tested, the EO/MC pair generated maximum polymorphism among the clinical isolates of M. tuberculosis. The similarity between the isolates ranged between 88 and 99.5%. Majority (nearly 85%) of the 'low copy' IS6110 isolates clustered together, while the rest clustered irrespective of the copy numbers. AFLP could show rare differences between isolates of M. tuberculosis, M. bovis and M. bovis BCG. The AFLP profiles for non-tuberculous mycobacteria were highly different from those of M. tuberculosis. CONCLUSION: Polymorphism generated by AFLP within the M. tuberculosis species is limited and hence AFLP alone seems to have limited use in fingerprinting the isolates in Kerala. The combined use of AFLP and IS6110-RFLP showed relatively better differentiation of 'high copy' IS6110 isolates, but failed to differentiate the 'low copy' isolates. However, the technique may be efficient in inter-species differentiation, and hence potentially useful in identifying and developing species- specific markers. BioMed Central 2007-07-28 /pmc/articles/PMC1950308/ /pubmed/17662148 http://dx.doi.org/10.1186/1471-2334-7-86 Text en Copyright © 2007 Krishnan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Krishnan, Manju Y
Radhakrishnan, Indulakshmi
Joseph, Biljo V
GK, Madhavi Latha
Kumar R, Ajay
Mundayoor, Sathish
Combined use of Amplified Fragment Length Polymorphism and IS6110-RFLP in fingerprinting clinical isolates of Mycobacterium tuberculosis from Kerala, South India
title Combined use of Amplified Fragment Length Polymorphism and IS6110-RFLP in fingerprinting clinical isolates of Mycobacterium tuberculosis from Kerala, South India
title_full Combined use of Amplified Fragment Length Polymorphism and IS6110-RFLP in fingerprinting clinical isolates of Mycobacterium tuberculosis from Kerala, South India
title_fullStr Combined use of Amplified Fragment Length Polymorphism and IS6110-RFLP in fingerprinting clinical isolates of Mycobacterium tuberculosis from Kerala, South India
title_full_unstemmed Combined use of Amplified Fragment Length Polymorphism and IS6110-RFLP in fingerprinting clinical isolates of Mycobacterium tuberculosis from Kerala, South India
title_short Combined use of Amplified Fragment Length Polymorphism and IS6110-RFLP in fingerprinting clinical isolates of Mycobacterium tuberculosis from Kerala, South India
title_sort combined use of amplified fragment length polymorphism and is6110-rflp in fingerprinting clinical isolates of mycobacterium tuberculosis from kerala, south india
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950308/
https://www.ncbi.nlm.nih.gov/pubmed/17662148
http://dx.doi.org/10.1186/1471-2334-7-86
work_keys_str_mv AT krishnanmanjuy combineduseofamplifiedfragmentlengthpolymorphismandis6110rflpinfingerprintingclinicalisolatesofmycobacteriumtuberculosisfromkeralasouthindia
AT radhakrishnanindulakshmi combineduseofamplifiedfragmentlengthpolymorphismandis6110rflpinfingerprintingclinicalisolatesofmycobacteriumtuberculosisfromkeralasouthindia
AT josephbiljov combineduseofamplifiedfragmentlengthpolymorphismandis6110rflpinfingerprintingclinicalisolatesofmycobacteriumtuberculosisfromkeralasouthindia
AT gkmadhavilatha combineduseofamplifiedfragmentlengthpolymorphismandis6110rflpinfingerprintingclinicalisolatesofmycobacteriumtuberculosisfromkeralasouthindia
AT kumarrajay combineduseofamplifiedfragmentlengthpolymorphismandis6110rflpinfingerprintingclinicalisolatesofmycobacteriumtuberculosisfromkeralasouthindia
AT mundayoorsathish combineduseofamplifiedfragmentlengthpolymorphismandis6110rflpinfingerprintingclinicalisolatesofmycobacteriumtuberculosisfromkeralasouthindia